Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Addex extends Merck
& Co research linkup 8:16 AM 12/2/2009
Reuters
Addex Pharmaceuticals extended a research deal with Merck & Co by a year seeking to
develop a treatment for Parkinson's disease. Addex's lead drug ADX10059 targets heartburn and migraine reaching
its main target in a late-stage trial.
...
Abbott settles Tricor patent
row with Teva 5:06 AM 12/2/2009
Reuters
Abbott
Laboratories Inc settled US patent litigation with Teva Pharmaceutical Industries over blockbuster
triglycerides drug Tricor. Teva might not receive rights until July 1, 2012.
...
Takeda
Plans to Enter India Drug Market to Bolster Sales Growth 4:46 AM 12/2/2009
Bloomberg
Takeda Pharmaceutical Co plans to enter the Indian market to tap
growth in emerging economies. The company's best-selling Actos diabetes pill loses patent protection in January
2011.
...
Santarus
gets FDA nod on heartburn drug 4:38 PM 12/1/2009
Forbes
Santarus Inc said it got marketing approval in the US for an over-the-counter version
of Schering-Plough Corp's heartburn drug Zegerid.
...
Teva seeks FDA nod for
biosimilar of Amgen drug 11:15 AM 12/1/2009
Reuters
In the absense of a biosimilar regulatory pathway, Teva Pharmaceutical Industries
submitted a Biologics License Application (BLA) treating XM02 (brand name TevaGrastim) as a new biotech
medicine hoping to compete with Amgen Inc's white blood cell booster Neupogen.
...
Bayer
acquires rights to Micromet's experimental drug 8:39 AM 12/1/2009
Reuters
Bayer exercised its option to buy the rights to a cancer-fighting BiTE
antibody from US biotech Micromet in a deal potentially worth $429 million in milestone payments.
...
Pfizer
acquires rights to Protalix's Gaucher drug 6:17 AM 12/1/2009
Reuters
Pfizer Inc will acquire the worldwide marketing rights to Protalix
BioTherapeutics Inc's experimental drug Uplyso for Gaucher's disease for an upfront payment of $60 million.
...
Pfizer
Will Start Generic-Drug Business in Japan 5:06 AM 12/1/2009
Bloomberg
Pfizer Inc will enter the generic-drug market in Japan as early as 2011
to bolster sales of its medicines that have lost patent protection.
...
FDA
Rejects Approval of MS Drug 4:46 AM 12/1/2009
Wall Street Journal
Merck KGaA's application for US approval of cladribine tablets for
multiple sclerosis was rejected by the US FDA for not being complete.
...
Inovio
Biomedical's hepatitis C vaccine progresses 10:40 AM 11/30/2009
Bizjournals.com
Inovio Biomedical Corp said drug-development partner Tripep
completed a phase-I clinical study of its ChronVac-C hepatitis C DNA vaccine using electroporation or
controlled millisecond electrical pulses that allow DNA-based vaccines to permeate cell membrane.
...
BioMarin
autoimmune disease drug gets orphan status 9:17 AM 11/30/2009
Reuters
BioMarin Pharmaceutical Inc's experimental treatment amifampridine phosphate
(3,4-diaminopyridine) as an experimental treatment for Lambert Eaton Myasthenic Syndrome (LEMS).
...
Enthusiasm
For Lupus Drug Fuels Human Genome Sciences Shares 7:27 AM 11/30/2009
Wall Street Journal
If approved, Human Genome Sciences Inc's Benlysta would be
the first new drug specifically approved to treat the debilitating autoimmune disease lupus.
...
Sanofi-Aventis
Cardiovascular Drug Multaq Gets EU Approval 5:00 AM 11/30/2009
Wall Street Journal
Sanofi-Aventis SA said its cardiovascular drug Multaq has been
approved for marketing in the European Union. Multaq was approved in the US last July. ...
...
Takeda: eyeing M&A
for generics in emerging markets 4:44 AM 11/30/2009
Reuters
Takeda Pharmaceutical is not interested in entering the generic market in Japan, but
could acquire a company to enter the generic drug business in emerging markets like South America.
...
New
WHO guidelines urge phase-out of major HIV drug 3:10 PM 11/29/2009
Reuters
Phase out the use of Stavudine because of long-term irreversible
side-effects in HIV patients including wasting and a nerve disorder. WHO advised that HIV-positive women and
babies take the drugs while breastfeeding to prevent mother-to-child transmission.
...
<- Day Earlier | Today's News
|
